$3.39-0.06 (-1.87%)
NeuroOne Medical Technologies Corporation, a medical technology company, provides solutions for continuous electroencephalogram (cEEG) and stereoelectrocencephalography (sEEG) recording in the United States.
NeuroOne Medical Technologies Corporation in the Healthcare sector is trading at $3.39 with a market capitalization of $29M. Wall Street consensus targets $9.93 (3 analysts), implying a +193.0% move over the next 12 months. The stock is currently near its 52-week low of $3.28, remaining 27.1% below its 200-day moving average. On fundamentals, Piotroski 6/9 shows mixed financial quality, Altman Z in the distress zone. Risk note: RSI 26 is oversold, raising the odds of a near-term bounce; MACD remains below its signal line. The Whystock Score of 70/100 reflects bullish alignment across trend, valuation and analyst targets.
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
NeuroOne Medical Technologies Corporation, a medical technology company, provides solutions for continuous electroencephalogram (cEEG) and stereoelectrocencephalography (sEEG) recording in the United States. The company also provides solutions for sp...
NeuroOne Medical Technologies Corp (NMTC) reports significant revenue growth and strategic advancements, despite facing profitability and cash flow challenges.
Despite a dip in revenue, NeuroOne Medical Technologies Corp (NMTC) showcases promising advancements and strategic partnerships for future growth.
Moby summary of NeuroOne Medical Technologies Corporation's Q1 2026 earnings call
ILPT, NMTC, RIGL, RIO and BHP have been added to the Zacks Rank #1 (Strong Buy) List on January 6th, 2026.
NeuroOne Medical Technologies Corp (NMTC) reports significant revenue growth, improved margins, and strategic progress despite challenges in compliance and international expansion.